PRAXIS PRECISION MEDICINES ANNOUNCES PLANS TO FILE AN NDA FOR RELUTRIGINE IN SCN2A AND SCN8A DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHIES IN EARLY 2026

Reuters · 2d ago

Please log in to view news